targeted Nectin4/NKG2DL/TROP2/B7H3/ FAP beast of Hi-TCR-T cells (Shanghai Sixth People's Hospital)

靶向Nectin4/NKG2DL/TROP2/B7H3/FAP的超能Hi-TCR-T细胞 (上海市第六人民医院)

Report date: 2026/04/16 20:00:17

Base Information

Drug Nametargeted Nectin4/NKG2DL/TROP2/B7H3/ FAP beast of Hi-TCR-T cells (Shanghai Sixth People's Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionCD276 antigen modulatorsNKG2D ligands modulatorsTumor-associated calcium signal transducer 2 modulators +[5] 
TargetsCD276 antigenNKG2D ligandsTumor-associated calcium signal transducer 2 +[5] 
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Sixth People'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Sixth People'S Hospital
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A